Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2004

FR Doc 04-18173 [Federal Register: August 10, 2004 (Volume 69, Number 153)] [Notices] [Page 48523] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr10au04-123]


Drug Enforcement Administration

Manufacturer of Controlled Substances, Notice of Registration

By notice dated March 5, 2004, and published in the Federal Register on March 15, 2004 (69 FR 12179), Lin Zhi International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of eleven basic classes of controlled substances in Schedule I and II. On April 13, 2004, the firm submitted a latter to DEA which stated that only six of the basic classes of controlled substances were intended for bulk manufacture. The corrected list of drug codes is as follows:

Drug  Schedule 
Tetrahydrocannabinols (7370) I
3,4-Methylenedioxymethamphetamine (7405) I
Cocaine (9041) II
Methadone (9250) II
Dextropropoxyphene (9273) II
Morphine (9300) II

The company plans to manufacture small quantities of controlled substances to make drug testing reagents and controls. 

No comments or objection have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lin Zhi International, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin Zhi International, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: July 28, 2004. 

Joseph T. Rannazzisi, 
Deputy Director, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 04-18173 Filed 8-9-04; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility